Acorn AI Intelligent Trials Case Study | BioPharma Company Doubles High-Performing Site Count in Priority Indication
Downloadable Case Study
A Top 10 Pharma Company Doubles High-Performing Site Count in a Priority Indication with Medidata Acorn AI Intelligent Trials
A top 10 biopharmaceutical company was looking to gain agility and confidence in their trial planning, site selection, and clinical trial enrollment decisions in a priority indication.
Currently, 80% of trials do not enroll within target enrollment timeframes and 55% of terminated trials cite low patient accrual as the main reason. In such a cut-throat environment, it was critical for this top sponsor to choose high-performing sites based on reliable data to set their trials up for success.
Download this case study to see how Intelligent Trials helped this company:
- Integrate cross-industry clinical trial data with their existing data
- Gain a more robust view of site performance, especially at sites with little data from other sources
- Double the number of high-performing sites identified in their priority indication